Advanced Imaging Techniques for Skin Cancer Diagnosis and Reduction of Unnecessary Biopsies
Advanced Imaging Techniques for Skin Cancer Diagnosis and Reduction of Unnecessary Biopsies
Date of Original Release: September 25, 2024
Date of Expiration: September 25, 2027
Estimated Time of Completion: 7 Hours
Target Audience
Dermatologists and others involved in the delivery of dermatologic care.
Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.
Learning Objectives
Following participation in this activity, the learner should be able to:
- Recognize imaging modalities to aid in the diagnosis of skin cancer
- Identify ways to reduce unnecessary or inadequate biopsies
- Describe the criteria to select the appropriate imaging modality to diagnose skin cancer
Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Credit Statement
The American Academy of Dermatology designates this enduring material for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Instructions to Claim Credit
To Claim CME credit for this activity, the learner must complete the post-activity evaluation survey.
Planner
Jane Grant-Kels, MD, FAAD
Professor and Chair Emeritus
University of Connecticut
Farmington, Connecticut
Reviewer
Dirk Elston, MD, FAAD
Professor and Chair Emeritus
Medical University of South Carolina
Charleston, South Carolina
Faculty
Ximena Wortsman, MD, FAIUM
Professor
Universidad de Chile
Santiago, Chile
Julia Welzel, MD
University Hospital Augsburg
Augsburg, Germany
Caterina Longo, MD, PhD, IFAAD
Professor
University of Modena and Reggio Emilia
Modena, Italy
Kishwer Nehal, MD, FAAD
Professor
Weill Cornell Graduate School of Medical Sciences
New York, New York
Margaret Oliviero-Rabinovitz, NP, MSN
Skin & Cancer Associates
Plantation, Florida
Harold Rabinovitz, MD, FAAD
Professor
Augusta University, Medical College of Georgia
Augusta, Georgia
Daniel Siegel, MD, MS, FAAD
Professor
SUNY Downstate Medical School
Brooklyn, New York
Hugues Cartier, MD
Clinic Saint-Jean
Arras, France
Diana Crisan, MD
Catholic Health Physician Partners
Centereach, New York
Nilton Di Chiacchio, MD, PhD
Clínica Dermatológica
São Paulo, Brazil
Antonio Martorell-Calatayud, MD, PhD
Hospital de Manises
Valencia, Spain
Paola Pasquali, MD, IFAAD
Pius Hospital de Valls
Tarragona, Spain
Sandra Schuh, MD
University Hospital Augsburg
Augsburg, Germany
Maria Tembra, MD, IFAAD
MF Tembra Dermatologia
Sao Paulo, Brazil
Cristian Vera Kellet, MD, IFAAD
Associate Professor
Pontificia Universidad Católica de Chile
Santiago, Chile
Fernando Alfageme, MD
Associate Professor
Autonomous University of Madrid
Madrid, Spain
Mariano Suppa, MD
Associate Professor
Hospital Erasme
Brussels, Belgium
Maria Jose Aldunce, MD
Clinica Opia
Las Condes, Región Metropolitana, Chile
Staff
Christine Presta
Director, Digital Learning
Rosemont, Illinois
Janet Chester
Manager, Learning Resources
Rosemont, Illinois
Emma Hostetler
Coordinator, Learning Resources
Rosemont, Illinois
Dustin Herlich
Manager, Digital Learning
Rosemont, Illinois
Melinda Keske
Senior Coordinator, Digital Learning
Rosemont, Illinois
Camilia Schawel
Instructional Designer, Digital Learning
Rosemont, IL
John Healy
Instructional Designer, Digital Learning
Rosemont, IL
Disclosures
Contributor Name
|
Commercial Interest
|
Financial Relationship
|
Compensation
|
Jane Grant-Kels, MD, FAAD
|
DermaSensor Inc
|
Advisory Board
|
None
|
Margaret Oliviero-Rabinovitz, NP, MSN
|
3Gen, LLC
|
Speaker
|
Honoraria
|
Margaret Oliviero-Rabinovitz, NP, MSN
|
Caliber Imaging and Diagnostics Inc.
|
Consultant
|
No Compensation Received
|
Margaret Oliviero-Rabinovitz, NP, MSN
|
DermaSensor Inc
|
Consultant (1099) relationship)
|
Honoraria
|
Paola Pasquali, MD, IFAAD
|
Dermosight
|
Advisory Board
|
None
|
Harold Rabinovitz, MD, FAAD
|
3Gen, LLC
|
Speaker
|
Equipment
|
Harold Rabinovitz, MD, FAAD
|
Caliber Imaging and Diagnostics Inc.
|
Investigator
|
Equipment
|
Harold Rabinovitz, MD, FAAD
|
Casio of America
|
Consultant (1099 relationship)
|
Salary
|
Harold Rabinovitz, MD, FAAD
|
DermaSensor Inc
|
Consultant
|
Fees
|
Harold Rabinovitz, MD, FAAD
|
Heine
|
Consultant
|
Equipment
|
Harold Rabinovitz, MD, FAAD
|
MetaOptima
|
Consultant (1099 relationship)
|
Fees
|
Julia Welzel, MD
|
DAMAE Medical
|
Investigator
|
Equipment
|
All other planners, speakers, reviewers, and staff for this activity have no relevant financial relationships with ineligible companies (formerly known as commercial interests).
Conflict Mitigation Statement
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content.
Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.
Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition.
No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.
Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.